Trials / Unknown
UnknownNCT02857959
One Dose Versus Three Weekly Doses of Benzathine Penicillin G for Patients With Early Syphilis
Doctor of Medicine
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Jun Li · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to observe the serological response to 1 or 3 weekly doses of benzathine penicillin G in patients with early syphilis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Benzathine Penicillin G |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2020-06-01
- Completion
- 2020-08-01
- First posted
- 2016-08-05
- Last updated
- 2018-11-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02857959. Inclusion in this directory is not an endorsement.